Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Polypropylene sulfide nanoparticle p24 vaccine promotes dendritic cell-mediated specific immune responses against HIV-1

Caucheteux, Stephan M., Mitchell, John P., Ivory, Matthew O. ORCID: https://orcid.org/0000-0002-8736-395X, Hirosue, Sachiko, Hakobyan, Svetlana, Dolton, Garry, Ladell, Kristin ORCID: https://orcid.org/0000-0002-9856-2938, Miners, Kelly, Price, David A. ORCID: https://orcid.org/0000-0001-9416-2737, Kan-Mitchell, June, Sewell, Andrew K. ORCID: https://orcid.org/0000-0003-3194-3135, Nestle, Frank, Moris, Arnaud, Karoo, Richard O., Birchall, James C. ORCID: https://orcid.org/0000-0001-8521-6924, Swartz, Melody A., Hubbel, Jeffrey A., Blanchet, Fabien P. and Piguet, Vincent 2016. Polypropylene sulfide nanoparticle p24 vaccine promotes dendritic cell-mediated specific immune responses against HIV-1. Journal of Investigative Dermatology 136 (6) , pp. 1172-1181. 10.1016/j.jid.2016.01.033

[thumbnail of Polypropylene sulfide nanoparticle p24 vaccine promotes dendritic cell-mediated specific immune responses against HIV-1 .pdf]
Preview
PDF - Accepted Post-Print Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (447kB) | Preview

Abstract

Delivery of vaccine formulations into the dermis using antigen-coated microneedle patches is a promising and safe approach because of efficient antigen delivery and safety. We evaluated an intradermal vaccine using HIV-1 p24 Gag peptide-conjugated polypropylene sulfide nanoparticles to induce immunity against HIV-1. This peptide-conjugated polypropylene sulfide nanoparticle formulation did not accelerate the maturation of blood- or skin-derived subsets of dendritic cells, either generated in vitro or purified ex vivo, despite efficient uptake in the absence of adjuvant. Moreover, dendritic cell-mediated capture of particulate antigen in this form induced potent HIV-1–specific CD4+ T-cell responses, as well as B-cell–mediated antibody production. Nanoparticle-based intradermal antigen delivery may therefore provide a new option in the global effort to develop an effective vaccine against HIV-1.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Pharmacy
Medicine
Subjects: Q Science > QR Microbiology > QR180 Immunology
Uncontrolled Keywords: DC, dendritic cell; ID, intradermal; LC, Langerhans cell; LPS, lipopolysaccharide; MDDC, monocyte-derived dendritic cell; MDLC, monocyte-derived Langerhans cell; NP, nanoparticle; p24, HIV-1 capsid protein; p24NP, HIV-1 p24 Gag peptide-conjugated polypropylene sulfide nanoparticle; TNF, tumor necrosis factor
Additional Information: Released with a Creative Commons Attribution Non-Commercial No Derivatives License (CC BY-NC-ND)
Publisher: Elsevier
ISSN: 0022-202X
Date of First Compliant Deposit: 11 April 2016
Date of Acceptance: 14 January 2016
Last Modified: 05 Feb 2023 12:46
URI: https://orca.cardiff.ac.uk/id/eprint/89071

Citation Data

Cited 16 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics